Literature DB >> 30151588

Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses.

Wen-Chun Liu1, Raffael Nachbagauer1, Florian Krammer1, Randy A Albrecht2,3.   

Abstract

Animal models are essential to examine the pathogenesis and transmission of influenza viruses and for preclinical evaluation of influenza virus vaccines. Among the animal models used in influenza virus research, the domestic ferret (Mustela putorius furo) is the gold standard. As seen in humans, infection with influenza virus or immunization with an influenza virus vaccine induces humoral and cellular immunity in ferrets that provides protection against infection by an antigenically similar influenza virus. Antibodies against the globular head domain of the influenza hemagglutinin can provide sterilizing immunity against virus infection by blocking receptor binding. However, antibodies that bind the stalk region of the hemagglutinin also confer protection by several mechanisms including antibody-dependent cellular cytotoxicity or phagocytosis. Recently, the antigenically and structurally conserved hemagglutinin stalk has become an attractive target for the development of universal influenza virus vaccines that hold the promise to provide protection against influenza epidemics and pandemics. Herein, in vivo and in vitro assays, including optimization of assay conditions to examine hemagglutinin stalk-specific antibody responses in small animal models, are described.

Entities:  

Keywords:  ELISA; ELISpot; Ferret; Flow cytometry; HI assay; Hemagglutinin stalk immunity; Influenza virus

Mesh:

Substances:

Year:  2018        PMID: 30151588     DOI: 10.1007/978-1-4939-8678-1_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants.

Authors:  Jenny E Hernandez-Davies; Emmanuel P Dollinger; Egest J Pone; Jiin Felgner; Li Liang; Shirin Strohmeier; Sharon Jan; Tyler J Albin; Aarti Jain; Rie Nakajima; Algimantas Jasinskas; Florian Krammer; Aaron Esser-Kahn; Philip L Felgner; Qing Nie; D Huw Davies
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

2.  Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.

Authors:  Wen-Chun Liu; Raffael Nachbagauer; Daniel Stadlbauer; Alicia Solórzano; Francesco Berlanda-Scorza; Adolfo García-Sastre; Peter Palese; Florian Krammer; Randy A Albrecht
Journal:  Front Immunol       Date:  2019-04-10       Impact factor: 7.561

3.  Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.

Authors:  Wen-Chun Liu; Raffael Nachbagauer; Daniel Stadlbauer; Shirin Strohmeier; Alicia Solórzano; Francesco Berlanda-Scorza; Bruce L Innis; Adolfo García-Sastre; Peter Palese; Florian Krammer; Randy A Albrecht
Journal:  Vaccines (Basel)       Date:  2021-01-11

4.  Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components.

Authors:  Jenny E Hernandez-Davies; Jiin Felgner; Shirin Strohmeier; Egest James Pone; Aarti Jain; Sharon Jan; Rie Nakajima; Algimantas Jasinskas; Erwin Strahsburger; Florian Krammer; Philip L Felgner; D Huw Davies
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.